A Phase III Study of Novel Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With an Anthracycline and a Taxane
Latest Information Update: 03 Nov 2020
At a glance
- Drugs Ixabepilone (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Bristol-Myers Squibb; R-Pharm
- 10 Jul 2010 Results published in JCO.
- 09 Oct 2008 Checked against ClinicalTrials.gov record. Last updated 9 October 2008.
- 05 Sep 2008 Primary endpoint 'Overall survival duration' has not been met.